Mode of action of a new hypocholesteraemic drug (DH-581) in familial hypercholesteraemia.
D000085:Acetates / Q000378:metabolism; D000328:Adult; D000368:Aged; D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D002247:Carbon Isotopes / Q000378:metabolism; D002784:Cholesterol / Q000097:blood; D005243:Feces / Q000032:analysis; D005260:Female; D006801:Humans; D006949:Hyperlipidemias / Q000188:drug therapy* / Q000235:genetics*; D008055:Lipids / Q000032:analysis / Q000097:blood; D008099:Liver / Q000032:analysis; D008297:Male; D008798:Mevalonic Acid / Q000378:metabolism; D008875:Middle Aged; D013256:Steroids / Q000032:analysis; D013997:Time Factors; D014280:Triglycerides / Q000097:blood; D014316:Tritium / Q000378:metabolism
D000085:Acetates; D000924:Anticholesteremic Agents; D002247:Carbon Isotopes; D008055:Lipids; D013256:Steroids; D014280:Triglycerides; D014316:Tritium; D002784:Cholesterol; D008798:Mevalonic Acid